Marcus Lehtinen

Parties

Optomed Plc

Transaction

Optomed’s IPO and listing on the Nasdaq Helsinki stock exchange

Deal Value

The offering by the company and its shareholders amounted to approximately EUR 44 million

Role

Counsel to Optomed Plc 

Parties
Polygon AB (publ)

Transaction
Polygon AB (publ) on its EUR 40 million subsequent bond issue

Deal Value

EUR 40 million

Role
Lead Counsel to Polygon AB (publ)

Counsel to Oasmia Pharmaceutical AB, listed on Nasdaq Stockholm, Mid Cap, on its SEK 399 million issue of new shares with preferential rights for existing shareholders

Parties

Logent AB, Stirling Square Capital Partners LLP

Transaction

Logent Group issue of SEK 900 Million Senior Secured Notes and the Entry Into of a Super Senior RCF

Deal Value

SEK 900 million

Role

Counsel to Logent Group and SSCP

Parties

SpareBank 1 Markets AS, Lundin Petroleum AB

Transaction

SpareBank 1 Markets AS in connection with transactions involving Lundin Petroleum AB, listed on Nasdaq Stockholm, Large Cap

Deal Value

SEK 14.5 billion

Role

Counsel to SpareBank 1 Markets AS

Parties

BVF Partners, Calliditas Therapeutics AB

Transaction

BVF Partners' Investment in Calliditas Therapeutics AB

Deal Value

SEK 300 million

Role

Counsel to BVF Partners